Study of Cannabidiol in Sanfilippo Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Cannabidiol in Sanfilippo Syndrome — Stella

Home/Sanfilippo Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Sanfilippo Syndrome trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Enrollment target

~35 participants

Started

April 2026

Primary completion

April 2027

Age range

4 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.